Trelegy ellipta 100-62.5-25 60S
Ended Awarded Last action
- Contract number
- SPE2DR26FG2BZ
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $22,483
Award facts
- Contract value 100% obligated
- $22,482.76 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on December 10, 2025, for the supply of Trelegy Ellipta 100-62.5-25 inhalation powder (60-dose units) with a contract value of $22,482.76. This is a firm fixed-price delivery order under a non-competitive, non-set-aside procurement. The award represents a child contract under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $1 billion global pharmaceutical prime vendor agreement running through December 2026. The place of performance is AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania, with an ultimate completion date of December 11, 2025.
Trelegy Ellipta is a combination respiratory medication used primarily for chronic obstructive pulmonary disease (COPD) management. This delivery order reflects the ongoing medical supply procurement needs of the Department of Defense and military healthcare systems to support service members and beneficiaries. AmerisourceBergen's role as a pharmaceutical prime vendor enables the efficient distribution of specialty medications and medical supplies across the military healthcare enterprise. The DLA Medical Supply Chain regularly issues delivery orders against the SPE2DX prime vendor contract to fulfill recurring pharmaceutical requirements, allowing for rapid fulfillment of critical healthcare commodities to support military operations and veteran care.
Quick answers
Who was awarded contract SPE2DR26FG2BZ?
SPE2DR26FG2BZ was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 10, 2025.
How much is contract SPE2DR26FG2BZ worth?
The government has obligated $22,483 on SPE2DR26FG2BZ.
Is contract SPE2DR26FG2BZ an order under another contract?
Yes. SPE2DR26FG2BZ is a delivery order under SPE2DR25D3016, an indefinite delivery contract.
Was contract SPE2DR26FG2BZ competed?
The extent of competition for SPE2DR26FG2BZ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award